
Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process 8-K, 6-K, Schedule 13G. We will support more forms in the future.
Filter by Form Type:
2025-12-23ASTCSCHEDULE 13GASTROTECH Corp - SCHEDULE 13G Filing SummaryMEDIUM
This filing reports that Skylark Partners I, LP has acquired a 5.4% ownership stake in ASTROTECH Corp as of September 29, 2025. The filing indicates that Skylark Partners I, LP beneficially owns 94,370 shares, with sole voting and dispositive power over these shares. The securities were not acquired or held for the pur...
Nano CapScientific & Technical Instrumentsownership +5.40%
2025-12-23LPCNSCHEDULE 13GSchedule 13G Filing by Squadron Capital Management LLC for Lipocine Inc.MEDIUM
Squadron Capital Management, LLC, along with Squadron Master Fund LP, Matthew Sesterhenn, and William Blank, has filed a Schedule 13G detailing their beneficial ownership of Lipocine Inc. common stock. Squadron Capital Management, LLC, acting as the investment adviser, may be deemed the beneficial owner of shares held ...
Nano CapBiotechnologyownership +9.00%
2025-12-23FGLSCHEDULE 13GStreeterville Capital LLC Beneficial Ownership Filing for Founder Group LtdMEDIUM
Streeterville Capital LLC, along with Streeterville Management LLC and John M. Fife, reported beneficial ownership of 2,734,397 shares of Founder Group Ltd's Ordinary Shares as of December 23, 2025. This represents 9.99% of the outstanding shares. The ownership is subject to a contractual cap of 9.99%, which is aggrega...
Nano CapEngineering & Constructionownership +9.90%
2025-12-23TENXSCHEDULE 13GSchedule 13G Filing by Perceptive Advisors LLC for Tenax Therapeutics, Inc.MEDIUM
Perceptive Advisors LLC, along with Joseph Edelman and Perceptive Life Sciences Master Fund, Ltd., has filed a Schedule 13G, reporting beneficial ownership of 439,142 shares of Tenax Therapeutics, Inc. common stock. This represents 7.0% of the outstanding shares as of November 11, 2025. Perceptive Advisors acts as the ...
Micro CapBiotechnologyownership +7.00%
2025-12-23RDHLSCHEDULE 13GSchedule 13G Filing by YA II PN, Ltd. for RedHill Biopharma Ltd.HIGH
YA II PN, Ltd. has filed a Schedule 13G, reporting beneficial ownership of 508,723 American Depositary Shares (ADSs) of RedHill Biopharma Ltd. as of December 19, 2025. This represents 9.9% of the outstanding ADSs. The filing was made pursuant to a Standby Equity Distribution Agreement (SEPA) entered into on the same da...
Nano CapDrug Manufacturers - Specialty & Genericownership +9.90%
2025-12-22ASNSSCHEDULE 13GL1 Capital Global Opportunities Master Fund, Ltd. Acquires 7.8% Stake in Actelis Networks IncMEDIUM
L1 Capital Global Opportunities Master Fund, Ltd. has acquired a 7.8% stake in Actelis Networks Inc, representing 500,000 shares of common stock. This acquisition was made on December 19, 2025. The filing also notes the existence of 500,000 Warrants to purchase shares, which are subject to a 4.99% beneficial ownership ...
Nano CapCommunication Equipmentownership +7.80%
2025-12-22SLMTSCHEDULE 13GSchedule 13G Filing by Electric Capital Partners, LLCMEDIUM
Electric Capital Partners, LLC, along with its affiliates Electric Capital Frontier Fund II, LP, Electric Capital Frontier Fund GP II, LLC, Electric Capital Venture Fund III, LP, and Electric Capital Venture Fund GP III, LLC, has filed a Schedule 13G, indicating beneficial ownership of Brera Holdings PLC Class B Ordina...
ownership +15.20%
Sponsored
2025-12-22CVSCHEDULE 13GShen Ching Hang Reports 8.5% Ownership in CapsoVision, Inc.MEDIUM
Shen Ching Hang, a resident of Hong Kong, has acquired beneficial ownership of 3,991,607 shares of CapsoVision, Inc. common stock, representing 8.5% of the class. This filing, designated as a SCHEDULE 13G, indicates that Shen Ching Hang exercises sole dispositive power and sole voting power over these shares. The acqui...
Small CapMedical Devicesownership +8.50%
2025-12-22ELWTSCHEDULE 13GLaurence W. Lytton Acquires 5.9% Stake in Elauwit Connection, Inc.MEDIUM
Laurence W. Lytton has acquired beneficial ownership of 390,879 shares of Elauwit Connection, Inc. common stock, representing 5.9% of the outstanding shares. This information is based on a Schedule 13G filing dated December 22, 2025, with an event date of December 15, 2025. Mr. Lytton holds sole voting and dispositive ...
ownership +5.90%
2025-12-22Brera Holdings PLCSCHEDULE 13GSchedule 13G Filing by Electric Capital Partners, LLCDuplicateMEDIUM
Electric Capital Partners, LLC, along with its affiliates Electric Capital Frontier Fund II, LP, Electric Capital Frontier Fund GP II, LLC, Electric Capital Venture Fund III, LP, and Electric Capital Venture Fund GP III, LLC, has filed a Schedule 13G, indicating beneficial ownership of Brera Holdings PLC Class B Ordina...
ownership +15.20%
2025-12-22STSSSCHEDULE 13GSchedule 13G Filing by Electric Capital Partners, LLCMEDIUM
Electric Capital Partners, LLC, along with its affiliates Electric Capital Frontier Fund II, LP, Electric Capital Frontier Fund GP II, LLC, Electric Capital Venture Fund III, LP, and Electric Capital Venture Fund GP III, LLC, have filed a Schedule 13G regarding their beneficial ownership of Sharps Technology Inc. commo...
Micro CapMedical Instruments & Suppliesownership +9.90%
2025-12-22GLOOSCHEDULE 13GJesus Fund Increases Stake in Gloo Holdings, Inc. to 12.3%HIGH
Jesus Fund, an investment entity, has acquired a significant stake in Gloo Holdings, Inc., now beneficially owning 1,250,000 shares, representing 12.3% of the Class A common stock. This acquisition, effective November 19, 2025, was reported on a Schedule 13G filing. The filing indicates that Madeline Taylor, representi...
ownership +12.30%
2025-12-22HCATSCHEDULE 13GHealth Catalyst, Inc. - Schedule 13G FilingMEDIUM
Stoney Lonesome HF LP, along with associated entities and individuals including Coghill Capital Management, LLC, Drake Helix Holdings, LLC, CDC Financial, Inc., and Clint D. Coghill, has filed a Schedule 13G statement regarding their beneficial ownership of Health Catalyst, Inc. common stock. As of December 22, 2025, S...
Micro CapHealth Information Servicesownership +5.30%
2025-12-22INABSCHEDULE 13GStonepine Capital Management, LLC Increases Stake in IN8BIO, Inc. to 9.9%HIGH
Stonepine Capital Management, LLC, along with Stonepine Capital, L.P. and Stonepine GP, LLC, has reported a significant increase in their beneficial ownership of IN8BIO, Inc. common stock, reaching a total of 1,007,990 shares, which constitutes 9.9% of the outstanding shares. This filing, designated as a Schedule 13G, ...
Nano CapBiotechnologyownership +9.90%
Sponsored
2025-12-22INDVSCHEDULE 13GMillennium Management LLC Filing for Indivior PLCMEDIUM
Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has filed a Schedule 13G regarding their beneficial ownership of Indivior PLC. The filing indicates that as of December 15, 2025, these entities collectively held 2,461,370 Ordinary Shares, representing 2.0% of the class. Thi...
Mid CapDrug Manufacturers - Specialty & Genericownership +2.00%
2025-12-22Gloo Holdings, Inc.SCHEDULE 13GJesus Fund Increases Stake in Gloo Holdings, Inc. to 12.3%DuplicateHIGH
Jesus Fund, an investment entity, has acquired a significant stake in Gloo Holdings, Inc., now beneficially owning 1,250,000 shares, representing 12.3% of the Class A common stock. This acquisition, effective November 19, 2025, was reported on a Schedule 13G filing. The filing indicates that Madeline Taylor, representi...
ownership +12.30%
2025-12-22ACTELIS NETWORKS INCSCHEDULE 13GL1 Capital Global Opportunities Master Fund, Ltd. Acquires 7.8% Stake in Actelis Networks IncDuplicateMEDIUM
L1 Capital Global Opportunities Master Fund, Ltd. has acquired a 7.8% stake in Actelis Networks Inc, representing 500,000 shares of common stock. This acquisition was made on December 19, 2025. The filing also notes the existence of 500,000 Warrants to purchase shares, which are subject to a 4.99% beneficial ownership ...
Nano CapCommunication Equipmentownership +7.80%
2025-12-22Elauwit Connection, Inc.SCHEDULE 13GLaurence W. Lytton Acquires 5.9% Stake in Elauwit Connection, Inc.DuplicateMEDIUM
Laurence W. Lytton has acquired beneficial ownership of 390,879 shares of Elauwit Connection, Inc. common stock, representing 5.9% of the outstanding shares. This information is based on a Schedule 13G filing dated December 22, 2025, with an event date of December 15, 2025. Mr. Lytton holds sole voting and dispositive ...
ownership +5.90%
2025-12-22INDIVIOR PLCSCHEDULE 13GMillennium Management LLC Filing for Indivior PLCDuplicateMEDIUM
Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has filed a Schedule 13G regarding their beneficial ownership of Indivior PLC. The filing indicates that as of December 15, 2025, these entities collectively held 2,461,370 Ordinary Shares, representing 2.0% of the class. Thi...
Mid CapDrug Manufacturers - Specialty & Genericownership +2.00%
2025-12-22Electric Capital Partners, LLCSCHEDULE 13GSchedule 13G Filing by Electric Capital Partners, LLCDuplicateMEDIUM
Electric Capital Partners, LLC, along with its affiliates Electric Capital Frontier Fund II, LP, Electric Capital Frontier Fund GP II, LLC, Electric Capital Venture Fund III, LP, and Electric Capital Venture Fund GP III, LLC, have filed a Schedule 13G regarding their beneficial ownership of Sharps Technology Inc. commo...
Micro CapMedical Instruments & Suppliesownership +9.90%
2025-12-22CapsoVision, IncSCHEDULE 13GShen Ching Hang Reports 8.5% Ownership in CapsoVision, Inc.DuplicateMEDIUM
Shen Ching Hang, a resident of Hong Kong, has acquired beneficial ownership of 3,991,607 shares of CapsoVision, Inc. common stock, representing 8.5% of the class. This filing, designated as a SCHEDULE 13G, indicates that Shen Ching Hang exercises sole dispositive power and sole voting power over these shares. The acqui...
Small CapMedical Devicesownership +8.50%
Sponsored
2025-12-22IN8BIO, INC.SCHEDULE 13GStonepine Capital Management, LLC Increases Stake in IN8BIO, Inc. to 9.9%DuplicateHIGH
Stonepine Capital Management, LLC, along with Stonepine Capital, L.P. and Stonepine GP, LLC, has reported a significant increase in their beneficial ownership of IN8BIO, Inc. common stock, reaching a total of 1,007,990 shares, which constitutes 9.9% of the outstanding shares. This filing, designated as a Schedule 13G, ...
Nano CapBiotechnologyownership +9.90%
2025-12-22Health Catalyst, Inc.SCHEDULE 13GHealth Catalyst, Inc. - Schedule 13G FilingDuplicateMEDIUM
Stoney Lonesome HF LP, along with associated entities and individuals including Coghill Capital Management, LLC, Drake Helix Holdings, LLC, CDC Financial, Inc., and Clint D. Coghill, has filed a Schedule 13G statement regarding their beneficial ownership of Health Catalyst, Inc. common stock. As of December 22, 2025, S...
Micro CapHealth Information Servicesownership +5.30%
2025-12-19BSFCSCHEDULE 13GSchedule 13G Filing by Quick Capital, LLC for Blue Star Foods Corp.MEDIUM
Quick Capital, LLC, a Wyoming-based entity, has filed a Schedule 13G with the SEC, reporting beneficial ownership of up to 9.99% of the outstanding shares of Blue Star Foods Corp. Common Stock as of December 19, 2025. The filing indicates that Quick Capital, LLC holds sole voting power and sole dispositive power over t...
ownership +9.99%
2025-12-19BNRSCHEDULE 13GCRCM LP Increases Stake in Burning Rock Biotech Ltd.MEDIUM
CRCM LP, along with CRCM Institutional Master Fund (BVI), Ltd., CRCM LLC, and Chun R. Ding, has filed a Schedule 13G, indicating a change in their beneficial ownership of Burning Rock Biotech Ltd. ADSs. As of December 19, 2025, CRCM LP holds 486,426 ADSs, representing a 5.38% ownership stake. This acquisition was not m...
Micro Capownership +5.38%